全文获取类型
收费全文 | 212篇 |
免费 | 71篇 |
国内免费 | 1篇 |
出版年
2024年 | 1篇 |
2023年 | 8篇 |
2022年 | 13篇 |
2021年 | 28篇 |
2020年 | 10篇 |
2019年 | 21篇 |
2018年 | 9篇 |
2017年 | 13篇 |
2016年 | 16篇 |
2015年 | 19篇 |
2014年 | 19篇 |
2013年 | 26篇 |
2012年 | 19篇 |
2011年 | 25篇 |
2010年 | 6篇 |
2009年 | 3篇 |
2008年 | 5篇 |
2007年 | 6篇 |
2006年 | 6篇 |
2005年 | 5篇 |
2003年 | 3篇 |
2002年 | 5篇 |
2001年 | 2篇 |
2000年 | 2篇 |
1999年 | 3篇 |
1998年 | 2篇 |
1995年 | 1篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1985年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有284条查询结果,搜索用时 15 毫秒
281.
Lanfang Jiang Zitong Zhao Leilei Zheng Liyan Xue Qimin Zhan Yongmei Song 《基因组蛋白质组与生物信息学报(英文版)》2017,15(3):208-217
Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive cancers in China, but the underlying molecular mechanism of ESCC is still unclear. Involvement of microRNAs has been demonstrated in cancer initiation and progression. Despite the reported function of miR-503 in several human cancers, its detailed anti-oncogenic role and clinical significance in ESCC remain undefined. In this study, we examined miR-503 expression by qPCR and found the downregulation of miR-503 expression in ESCC tissue relative to adjacent normal tissues. Further investigation in the effect of miR-503 on ESCC cell proliferation, migration, and invasion showed that enhanced expression of miR-503 inhibited ESCC aggressive phenotype and overexpression of CCND1 reversed the effect of miR-503-mediated ESCC cell aggressive phenotype. Our study further identified CCND1 as the target gene of miR-503. Thus, miR-503 functions as a tumor suppressor and has an important role in ESCC by targeting CCND1. 相似文献
282.
283.
房室结多径路在临床中常见,其食道电生理有较典型特征,如多种频率心动过速。我们发现一例食道调搏存在两种频率心动过速患者,第一次在右延伸处成功慢径改良后较长时间不能发现另一条慢径存在,40分钟后另一条慢径才表现并于左延长处成功消融。提示如食道电生理发现存在多径路时心内电生理一定要多次重复检查,必要时延长观察时间,力争一次完整消融多条径路。 相似文献
284.
Yujing Xuan Yuqiao Sheng Daiqun Zhang Kai Zhang Zhen Zhang Yu Ping Shumin Wang Xiaojuan Shi Jingyao Lian Kangdong Liu Yi Zhang Feng Li 《Translational oncology》2021,14(8)
Esophageal cancer, including esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), has a poor prognosis and limited therapeutic options. Chimeric antigen receptor (CAR)-T cells represent a potential ESCC treatment. In this study, we examined CD276 expression in healthy and esophageal tumor tissues and explored the tumoricidal potential of CD276-targeting CAR-T cells in ESCC. CD276 was strongly and homogenously expressed in ESCC and EAC tumor lesions but mildly in healthy tissues, representing a good target for CAR-T cell therapy. We generated CD276-directed CAR-T cells with a humanized antigen-recognizing domain and CD28 or 4–1BB co-stimulation. CD276-specific CAR-T cells efficiently killed ESCC tumor cells in an antigen-dependent manner both in vitro and in vivo. In patient-derived xenograft models, CAR-T cells induced tumor regression and extended mouse survival. In addition, CAR-T cells generated from patient T cells demonstrated potent cytotoxicity against autologous tumor cells. Our study indicates that CD276 is an attractive target for ESCC therapy, and CD276-targeting CAR-T cells are worth testing in ESCC clinical trials. 相似文献